X-GalNAc

• CAT Number: M108295
• CAS Number: 129572-48-1
• Molecular Formula: C16H18BrClN2O6
• Molecular Weight: 449.68
• Purity: ≥95%
• Synonyms: N-[(2S,4S,5R)-2-[(5-bromo-4-chloro-1H-indol-3-yl)oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
• IUPAC Name: N-[(2S,3R,4R,5R,6R)-2-[(5-bromo-4-chloro-1H-indol-3-yl)oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
• InChI: InChI=1S/C16H18BrClN2O6/c1-6(22)20-13-15(24)14(23)10(5-21)26-16(13)25-9-4-19-8-3-2-7(17)12(18)11(8)9/h2-4,10,13-16,19,21,23-24H,5H2,1H3,(H,20,22)/t10-,13-,14+,15-,16-/m1/s1
• InChIKey: SUWPNTKTZYIFQT-LMXXTMHSSA-N
• SMILES: CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1OC2=CNC3=C2C(=C(C=C3)Br)Cl)CO)O)O

X-GalNAc（Cat No.:M108295）is a synthetic compound consisting of a galactosamine (GalNAc) sugar linked to a chromogenic substrate. It is widely used in glycosylation studies and enzymatic assays, particularly to detect specific glycosyltransferase activities. X-GalNAc acts as a substrate for enzymes that transfer GalNAc to other molecules, enabling researchers to study glycosylation processes and the role of carbohydrate modifications in biological systems. The compound is often employed in diagnostic applications, cell-based assays, and the development of novel glycosylation inhibitors, contributing to research in cancer, autoimmune diseases, and infectious diseases.